Tag: Europe
-
Open-Source Discovery Seeks Neglected Disease Drug
An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected.
-
FDA Approves Wearable Epilepsy Seizure Detector
The U.S. Food and Drug Administration approved a device worn like a wristwatch that uses a machine-learning algorithm to detect convulsive seizures in people with epilepsy.
-
Brain Wave Data Harnessed for Open-Source Brain Model
A lab in Germany created a technique for discovering a person’s neurological patterns from brain waves captured with a headset and simulated with population-wide brain data run on open-source software.
-
Sanofi Buys Nano-Antibody Biotech in $4.8B Deal
Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion.
-
Nerve Stimulation Shown to Treat Cluster Headaches
A device that stimulates a collection of nerves located behind the nose was shown in a year-long study to lower intensity and frequency of cluster headaches, a condition marked by repeating episodes of severe pain.
-
Institute Using Software to Boost Results Reproducibility
A genomics research lab in the U.K. is adding software to automate data collection that its developer says can improve the productivity of scientists and reproducibility of their findings.
-
Blood Disorder Drug Maker Acquired in $11.6B Deal
The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders.
-
Institute, Company Partner on Implanted Neuro Device
A research center in Switzerland and medical engineering company in Germany are developing an implanted device to measure signals and treat disorders affecting the brain.
-
Limited Industry Progress Seen on Microbial Resistance
A pharmaceutical industry coalition documents some advances after 2 years in developing better products and practices against antimicrobial resistance, but progress is limited and uneven.
-
Nerve Stimulation Shown to Reduce Diabetes Symptoms
Electric stimulation of a key nerve pathway was shown in lab animals to restore insulin sensitivity and glucose tolerance typically missing in people with type 2 diabetes.